BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22426945)

  • 21. Management of the clinically positive axilla.
    Euhus DM
    Breast J; 2020 Jan; 26(1):35-38. PubMed ID: 31876073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt.
    Dominici LS; Sineshaw HM; Jemal A; Lin CC; King TA; Freedman RA
    Breast Cancer Res Treat; 2018 Jan; 167(2):555-566. PubMed ID: 28990127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer.
    Straver ME; Loo CE; Alderliesten T; Rutgers EJ; Vrancken Peeters MT
    Br J Surg; 2010 Aug; 97(8):1226-31. PubMed ID: 20602508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.
    Newman EA; Sabel MS; Nees AV; Schott A; Diehl KM; Cimmino VM; Chang AE; Kleer C; Hayes DF; Newman LA
    Ann Surg Oncol; 2007 Oct; 14(10):2946-52. PubMed ID: 17514407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
    Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
    Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axillary node staging for microinvasive breast cancer: is it justified?
    Lyons JM; Stempel M; Van Zee KJ; Cody HS
    Ann Surg Oncol; 2012 Oct; 19(11):3416-21. PubMed ID: 22576061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer.
    Barry P; Vatsiou A; Spiteri I; Nichol D; Cresswell GD; Acar A; Trahearn N; Hrebien S; Garcia-Murillas I; Chkhaidze K; Ermini L; Huntingford IS; Cottom H; Zabaglo L; Koelble K; Khalique S; Rusby JE; Muscara F; Dowsett M; Maley CC; Natrajan R; Yuan Y; Schiavon G; Turner N; Sottoriva A
    Clin Cancer Res; 2018 Oct; 24(19):4763-4770. PubMed ID: 29891724
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
    Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
    Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axillary lymph node dissection for breast cancer: a decision analysis of T1 lesions.
    Velanovich V
    Ann Surg Oncol; 1998 Mar; 5(2):131-9. PubMed ID: 9527266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
    Kuerer HM; Sahin AA; Hunt KK; Newman LA; Breslin TM; Ames FC; Ross MI; Buzdar AU; Hortobagyi GN; Singletary SE
    Ann Surg; 1999 Jul; 230(1):72-8. PubMed ID: 10400039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is information from axillary dissection relevant to patients with clinically node-negative breast cancer?
    Chua B; Ung O; Taylor R; Boyages J
    Breast J; 2003; 9(6):478-84. PubMed ID: 14616942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor-positive breast cancer and clinically negative axillary nodes.
    Orr RK; Col NF; Kuntz KM
    Surgery; 1999 Sep; 126(3):568-76. PubMed ID: 10486611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of supraclavicular lymph node metastasis in breast carcinoma.
    Chen SC; Chen MF; Hwang TL; Chao TC; Lo YF; Hsueh S; Chang JT; Leung WM
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):614-9. PubMed ID: 11849781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
    Madekivi V; Boström P; Aaltonen R; Vahlberg T; Salminen E
    Anticancer Res; 2017 Jul; 37(7):3757-3762. PubMed ID: 28668871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
    Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
    Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice.
    El Hage Chehade H; Headon H; Kasem A; Mokbel K
    Anticancer Res; 2016 Apr; 36(4):1461-71. PubMed ID: 27069121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.